Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Allergy & Immunology Physician in Santa Monica, CA
NPI: 1447376454Primary Employer
Aire Medical La
sneezewheeze.com
HQ Phone
Get M.D. Raffi's Phone NumberMobile
Get M.D. Raffi's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2004 - 2026
American Board of Allergy and Immunology
Allergy & Immunology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Allergy and Immunology
Until 2007
Morehouse School Of Medicine
msm.edu
Medical School
Until 2001
Mass General Brigham/Massachusetts General Hospital
Residency • Pediatrics
2001 - 2004
Internship • Pediatrics
2001 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 109 | 239 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 74 | 74 |
| 3 | 95004Injection of allergenic extracts into skin, accessed through the skin | 67 | 6,446 |
| 4 | 95024Injection of allergenic extracts into skin for immediate reaction analysis | 56 | 1,381 |
| 5 | 99212Established patient outpatient visit, total time 10-19 minutes | 39 | 404 |
Authors: Güriş, D, Strebel, P M, Bardenheier, B, Brennan, M, Tachdjian, R, Finch, E, Wharton, M, Livengood, J R
Journal: Clin Infect Dis
Long-term prevention of hereditary angioedema attacks with lanadelumab in adolescents.
Authors: Jonathan Bernstein, Timothy Craig, John Anderson, Jonathan Bernstein
Journal: Ann Allergy Asthma Immunol
Publication Date: 2024-08-10
Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma
Lead Sponsor: Shire
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: DRUG: Lanadelumab 150 mg, DRUG: Lanadelumab 300 mg
Lead Sponsor: Shire
Intervention / Treatment: DRUG: Lanadelumab
Lead Sponsor: Takeda
Collaborators: Takeda Development Center Americas, Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: Lanadelumab